Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TADA2B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | SMARCB1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | ZNF490 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | NAV2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | SBF1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | MOAP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | FOXN3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | PCDHA12 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | DGKE | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |